Total Payments
$5,590
2024 Payments
$1,153
Companies
35
Transactions
326
Medicare Patients
3,839
Medicare Billing
$170,438
Payment Breakdown by Category
Food & Beverage$5,590 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,590 | 326 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,226 | 69 | $0 (2024) |
| ABBVIE INC. | $1,177 | 66 | $0 (2024) |
| GlaxoSmithKline, LLC. | $601.59 | 43 | $0 (2024) |
| PFIZER INC. | $463.79 | 28 | $0 (2024) |
| Astellas Pharma US Inc | $273.36 | 16 | $0 (2024) |
| Lilly USA, LLC | $244.73 | 15 | $0 (2024) |
| Amgen Inc. | $243.84 | 14 | $0 (2024) |
| Amarin Pharma Inc. | $207.97 | 9 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $168.52 | 10 | $0 (2022) |
| Esperion Therapeutics, Inc. | $157.02 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,153 | 69 | Novo Nordisk Inc ($325.05) |
| 2023 | $1,262 | 72 | ABBVIE INC. ($333.82) |
| 2022 | $1,212 | 68 | ABBVIE INC. ($320.55) |
| 2021 | $1,963 | 117 | AbbVie Inc. ($335.44) |
All Payment Transactions
326 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: PAIN | ||||||
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Biological | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $16.57 | General |
| Category: Medical Device | ||||||
| 10/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.54 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Neuromodulation | ||||||
| 09/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Biological | ||||||
| 09/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: PAIN | ||||||
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: PAIN | ||||||
| 08/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Obesity | ||||||
| 08/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 996 | 1,384 | $148,990 | $42,942 |
| 2022 | 17 | 896 | 1,188 | $149,501 | $43,697 |
| 2021 | 16 | 996 | 1,316 | $154,950 | $46,338 |
| 2020 | 16 | 951 | 1,272 | $146,765 | $37,461 |
Total Patients
3,839
Total Services
5,160
Medicare Billing
$170,438
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 209 | $47,025 | $14,287 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 100 | 100 | $34,100 | $10,938 | 32.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 30 | $9,090 | $3,137 | 34.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 59 | 75 | $9,375 | $2,176 | 23.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 88 | 120 | $8,520 | $1,975 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 36 | $5,508 | $1,552 | 28.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 85 | 114 | $6,498 | $1,496 | 23.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 93 | 129 | $5,805 | $1,335 | 23.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 59 | 77 | $4,928 | $1,138 | 23.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 93 | 133 | $1,197 | $1,117 | 93.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 96 | 137 | $4,521 | $1,043 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,296 | $931.86 | 21.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $1,275 | $514.08 | 40.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 32 | 47 | $1,927 | $447.44 | 23.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 41 | $3,075 | $370.11 | 12.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 15 | 15 | $930.00 | $283.80 | 30.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 68 | 92 | $920.00 | $200.54 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 173 | $38,925 | $12,817 | 32.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 101 | 101 | $34,441 | $11,184 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 87 | 130 | $19,890 | $5,767 | 29.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 32 | $9,696 | $3,471 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $10,024 | $1,963 | 19.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 73 | 96 | $6,816 | $1,577 | 23.1% |
| 82306 | Vitamin d-3 level | Office | 2022 | 38 | 48 | $6,000 | $1,407 | 23.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 74 | 95 | $5,415 | $1,244 | 23.0% |
About Veronica Hardman
Veronica Hardman is a Registered Nurse healthcare provider based in Ocala, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2017. The National Provider Identifier (NPI) number assigned to this provider is 1629580683.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Veronica Hardman has received a total of $5,590 in payments from pharmaceutical and medical device companies, with $1,153 received in 2024. These payments were reported across 326 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,590).
As a Medicare-enrolled provider, Hardman has provided services to 3,839 Medicare beneficiaries, totaling 5,160 services with total Medicare billing of $170,438. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Ocala, FL
- Active Since 10/31/2017
- Last Updated 02/10/2022
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1629580683
Products in Payments
- Ozempic (Drug) $747.54
- VRAYLAR (Drug) $578.39
- TRELEGY ELLIPTA (Drug) $560.96
- Rybelsus (Drug) $363.17
- QULIPTA (Drug) $269.64
- UBRELVY (Drug) $212.04
- Vascepa (Drug) $207.97
- ELIQUIS (Drug) $192.66
- Livalo (Drug) $168.52
- Otezla (Drug) $162.59
- JARDIANCE (Drug) $158.16
- NURTEC ODT (Drug) $146.02
- NEXLETOL (Drug) $138.31
- Veozah (Drug) $116.28
- MYRBETRIQ (Drug) $93.09
- Wegovy (Drug) $72.56
- MOUNJARO (Drug) $70.79
- SOLIQUA 100/33 (Biological) $64.17
- TRULICITY (Drug) $59.89
- EMGALITY (Drug) $56.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Ocala
Lorelly Mobley, Np, NP
Registered Nurse — Payments: $6,287
Registered Nurse $6,287
Anthony Torres, Aprn, APRN
Registered Nurse — Payments: $3,536
Registered Nurse $3,536
Stephani Carver, Aprn, APRN
Registered Nurse — Payments: $3,087
Registered Nurse $3,087
Daniel Schmidt
Registered Nurse — Payments: $2,438
Registered Nurse $2,438
Mrs. Amber Vanrijk, Np-C, NP-C
Registered Nurse — Payments: $1,498
Registered Nurse $1,498
Virginia Knott, Crna, CRNA
Registered Nurse — Payments: $1,000
Registered Nurse $1,000